The Trade Desk (NASDAQ: TTD) has a reputation for beating expectations, which worked against it in the latest investor update ...

The most likely curb on Trump’s tariff proclivities would be a sustained fall in stock prices. U.S. trade policy has been on ...

See our picks of the best free stock trading apps with no commission fees, user-friendly interfaces, and valuable research ...

Since going public in October of 2020, Palantir is up an incredible 1,105% and trades at a mind-boggling 200 times forward ...

Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...

Shares of The Trade Desk (TTD) have collapsed and are down 26% after the digital content and online advertising company ...

Ascendis Pharma beat Q4 earnings and revenue estimates, driven by a $100M Novo Nordisk deal and Yorvipath's EU launch.

Neurocrine Biosciences Inc. (NASDAQ:NBIX) reported fourth-quarter adjusted EPS of $1.69, higher than the $1.54 reported a ...

Regarding market opportunities in the semiconductor industry, Intel (INTC) no longer commands the social cachet it once did ...

Despite challenges like avian flu and GLP-1s, Tyson's protein products remain essential, especially for those on exercise ...